-
Mashup Score: 5Cancer care in times of crisis: an interview with Julie Gralow - 1 year(s) ago
Julie Gralow discusses sustaining cancer care during natural disasters and times of crisis in this exclusive interview.
Source: Oncology CentralCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0Patient characteristics associated with dose modifications for VRd among newly diagnosed multiple myeloma patients - 1 year(s) ago
An article from our partner journal Future Oncolgy explores the characteristics of newly diagnosed multiple myeloma patients with dose modified VRd regimens.
Source: Oncology CentralCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
An article from our partner journal @FutureOncol_FSG explores the characteristics of newly diagnosed #multiplemyeloma patients with dose modified VRd regimens. Read the full article here >>> https://t.co/poQAjncaai
-
-
Mashup Score: 0Top 3 Future Oncology articles - October 2022 - 1 year(s) ago
In the latest instalment of her regular column, Rosanna Zolna, Senior Commissioning Editor of Future Oncology, exclusively shares her top 3 peer-reviewed articles from recent journal issues, which we have made freely available for you, Oncology Central members! Check out Rosanna’s highlights below! Long-term effects of COVID-19 on cancer patients: the experience from Guy’s Cancer […]
Source: Oncology CentralCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
The long-term effects of #COVID-19 is yet to be comprehensively established – in our roundup of key articles of @FutureOncol_FSG articles find out about the effect of COVID-19 on #cancer patients and much more! >>>https://t.co/3wdsLVQTJU
-
-
Mashup Score: 0The extraordinary case of an individual surviving 12 tumors and the diagnostic opportunities of single-cell analysis - 1 year(s) ago
Unique case of individual carrying two mutated versions of MAD1L1 surviving twelve tumors, provides insight into cancer diagnosis earlier than previously imagined.
Source: Oncology CentralCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Recently published research from the @CNIOStopCancer details how a patient with mutated MAD1L1 genes, ended up enduring 12 #tumors. The same rare mutations that resulted in these tumors, confusingly also aided in her recovery. https://t.co/1wcUe8Qsto
-
-
Mashup Score: 0The extraordinary case of an individual surviving 12 tumors and the diagnostic opportunities of single-cell analysis - 1 year(s) ago
Unique case of individual carrying two mutated versions of MAD1L1 surviving twelve tumors, provides insight into cancer diagnosis earlier than previously imagined.
Source: Oncology CentralCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Single cell analysis may offer earlier #cancer diagnosis than was ever previously thought possible. Read about the extraordinary case that led researchers to this conclusion on Oncology Central >>> https://t.co/FAmmrqWexz
-
-
Mashup Score: 0Phase I trial of the DLL3/CD3 bispecific T-cell engager BI 764532 in DLL3-positive small-cell lung cancer and neuroendocrine carcinomas - 1 year(s) ago
Here we describe the rationale for, and design of, a clinical study of BI 764532 in patients with small cell lung cancer and other tumors containing DLL3.
Source: Oncology CentralCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Discover the ongoing study that is determining the maximum tolerated dose and evaluating safety, tolerability, pharmacokinetics and preliminary efficacy of BI 764532 monotherapy #Phase1 OpenAccess Find out more here >>> https://t.co/JbcCnaCfFr https://t.co/ksil9gGNv5
-
-
Mashup Score: 0
When diagnosed early, melanoma is far easier to treat and timely treatment saves lives, check out this guide to find out more.
Source: Oncology CentralCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Find out the risk factors for melanoma plus a simple practical algorithm to assess suspicious moles in our latest opinion piece from @focusonmelanoma >>>https://t.co/OPMrPsZJpK
-
-
Mashup Score: 0Top 3 Future Oncology articles - October 2022 - 2 year(s) ago
In the latest instalment of her regular column, Rosanna Zolna, Senior Commissioning Editor of Future Oncology, exclusively shares her top 3 peer-reviewed articles from recent journal issues, which we have made freely available for you, Oncology Central members! Check out Rosanna’s highlights below! Long-term effects of COVID-19 on cancer patients: the experience from Guy’s Cancer […]
Source: Oncology CentralCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
In our latest roundup, written by Rosanna Zolna, discover the latest exclusive research and review articles from Future Oncology @FutureOncol_FSG >>> https://t.co/HmkeugIr0k
-
-
Mashup Score: 0Simple blood test could detect rhabdomyosarcoma in children - 2 year(s) ago
Pilot study indicates the potential of liquid biopsies as prognostic tools in the treatment of pediatric rhabdomyosarcoma patients.
Source: Oncology CentralCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Out with the old, in with the new! Could solid biopsies become a thing of the past? Take a look at the latest installation of research exploring the potential of liquid biopsies: https://t.co/JDu8hGjxsv
-
-
Mashup Score: 0Simple blood test could detect rhabdomyosarcoma in children - 2 year(s) ago
Pilot study indicates the potential of liquid biopsies as prognostic tools in the treatment of pediatric rhabdomyosarcoma patients.
Source: Oncology CentralCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
A new study from @ICR_London suggests that a simple blood test can detect the relapse and development of rhabdomyosarcoma in children. Read all about it here on @OncologyCentral: https://t.co/vMnmbWFjiD
-
New in @OncologyCentral: ASCO CMO Dr. @jrgralow discusses what it takes to prevent cancer care from being disrupted in the midst of a crisis, with a particular focus on the war in Ukraine. https://t.co/OjHWCE2HES